Stay updated on Isatuximab/Len in MRD+ MM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab/Len in MRD+ MM Clinical Trial page.

Latest updates to the Isatuximab/Len in MRD+ MM Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, signaling an updated release. The Back to Top link has been removed, a minor navigational change.SummaryDifference0.7%
- Check12 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.7%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference14%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check40 days agoChange DetectedThe page has updated the date of the study on Post-Autologous Transplant Maintenance with Isatuximab and Lenalidomide in Multiple Myeloma from January 13, 2025, to August 6, 2025, and has revised the version number from v2.16.10 to v2.16.11.SummaryDifference1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Isatuximab/Len in MRD+ MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab/Len in MRD+ MM Clinical Trial page.